• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Box Office: ‘Venom’ Sequel Feasts on Monstrous $90 Million Debut, Setting Pandemic Record

October 3, 2021 by David Barret Leave a Comment

October 3, 2021

By Rebecca Rubin

LOS ANGELES (Variety.com) – “Venom: Let There be Carnage” roared to $90.1 million in its debut, setting a new pandemic record. It’s an impressive result, one that provides a lifeline to struggling movie theaters and (once again) proves Marvel’s might at the box office.

The much darker “Venom” follow-up comes from Sony Pictures and is separate from Disney’s Marvel Cinematic Universe, which recently delivered “Shang-Chi and the Legend of the Ten Rings” and “Black Widow” — the two highest-grossing films of the year at the domestic box office. If its first three days in theaters are any indication, “Venom: Let There be Carnage” looks to find itself among that group as 2021’s biggest earners. The film is playing only in cinemas as opposed to a hybrid release on-demand, a factor that should help ticket sales.

“We are also pleased that patience and theatrical exclusivity have been rewarded with record results,” Sony’s chairman Tom Rothman said in a statement to press. “With apologies to Mr. Twain: The death of movies has been greatly exaggerated.”

The supervillain sequel, starring Tom Hardy as the otherworldly lethal protector, blew past the pandemic-era benchmark set last July by “Black Widow,” which opened to $80 million in theaters. It made an additional $60 million on Disney Plus, where it was available to purchase on the same day as its theatrical debut.

“Young adult audiences are less deterred by current pandemic conditions than older and family moviegoers, which is benefitting superhero, action and horror movies,” says David A. Gross, who runs the movie consulting firm Franchise Entertainment Research. He adds: “For these movies, playing exclusively on the big screen is clearly an advantage.”

Making inaugural ticket sales for “Venom: Let There be Carnage” even more impressive: It had a bigger opening weekend than its predecessor, 2018’s “Venom.” The first comic book adventure with Hardy at the helm opened to $80 million, years before the devastating global health crisis. Despite terrible reviews, the original became a box office juggernaut and grossed $213 million in North America and $856 million globally. “Venom” was particularly huge in China, where the 2018 movie collected $269 million.

The sequel doesn’t have a release date yet in China, a market that will be crucial to its success. Though it is expected to open there, the country has denied “Black Widow,” “Shang-Chi and the Legend of the Ten Rings” and other major Hollywood titles.

“Venom: Let There be Carnage” wasn’t the only new movie to inject some life into the box office. MGM’s animated adventure “The Addams Family 2” pulled in a better-than-expected $18 million from 4,207 theaters while it was simultaneously available to rent on-demand.

Meanwhile, the Warner Bros. movie “The Many Saints of Newark,” a prequel to “The Sopranos,” flopped in its debut, generating a paltry $5 million from 3,181 venues. Like the studio’s entire 2021 slate, the film opened concurrently on HBO Max at no extra cost to subscribers.

Elsewhere at the domestic box office, “Shang-Chi” collected $6 million in its fifth weekend of release, boosting its overall total to $206 million. It’s the first, and so far only, pandemic-era movie to gross more than $200 million in the U.S. and Canada. The superhero tentpole has generated $386 million globally, which is far less than a Marvel movie would make in non-COVID times but ranks as one of the best hauls at a time when attendance hasn’t come close to reaching pre-pandemic levels.

Source Link Box Office: ‘Venom’ Sequel Feasts on Monstrous $90 Million Debut, Setting Pandemic Record

David Barret
David Barret

Related posts:

  1. HPE signs multi-billion dollar NSA computing deal
  2. EU’s chief executive warns against ‘pandemic of the unvaccinated’
  3. Ghana’s economy grew by 8.9% in second quarter, president says
  4. U.S. chipmaker Micron forecasts first-quarter revenue below estimates

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Invasive, Venomous Ants Lived Under The Radar In The US For 90 Years – Now They’re Spreading
  • Updated Prognosis: The Universe May End 10¹⁰²² Years Sooner Than We Thought
  • When You Get Your Fingers Wet They Wrinkle In The Same Pattern Every Time
  • World-First Footage Shows The Devastating Impact Of Trawling As It’s Happening
  • Blue Galdieria Algae Extract Among 3 Natural Food Dyes Newly Approved By FDA
  • Plastic Chemicals May Delay The Internal Body Clock By 17 Minutes, According To Study
  • Widespread Availability Of RSV Vaccine Linked To Fall In Baby Hospitalizations
  • How Often Should You Wash Your Bedding?
  • What’s The Youngest Language In The World?
  • Look Alert: The Most Active Volcano In the Pacific Northwest Is Probably About To Blow, Maybe
  • Should We Be Using Microwaves?
  • What Is The Largest Deer On Earth?
  • World’s First CRISPR-Edited Spider Produces Glowing Red Silk From Its Spinneret
  • First Ever Image Of “Free Floating” Atoms, The Nocebo Effect Beats The Placebo Effect When It Comes To Pain, And Much More This Week
  • 165-Million-Year-Old Fossil Is New Species Of Ancient Parasite. Did It Come From A Dinosaur’s Butt?
  • It’s True: Time Really Does Move Slower When You’re Exercising
  • Salmon Make Some Of The Most Epic Migrations In Nature. Why Do They Bother?
  • The Catholic Apostolic Church In Albury Has Been Sealed “Until The Second Coming”
  • The Voynich Manuscript Appears To Follow Zipf’s Law. Could It Be A Real Language?
  • When Will All Life On Earth Die Out? Here’s What The Data Says
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version